Ignite Creation Date:
2024-05-05 @ 11:08 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00003961
Status:
COMPLETED
Last Update Posted:
2014-04-17
First Post:
1999-11-01
Brief Title:
Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Conditions & Keywords Data
Conditions:
| Name |
|---|
| MyelodysplasticMyeloproliferative Diseases |
| Leukemia |
| Myelodysplastic Syndromes |
Keywords:
| Name | View |
|---|---|
| myelodysplasticmyeloproliferative disease unclassifiable | View |
| refractory anemia with excess blasts | View |
| refractory anemia with excess blasts in transformation | View |
| chronic myelomonocytic leukemia | View |
| de novo myelodysplastic syndromes | View |
| previously treated myelodysplastic syndromes | View |
| secondary myelodysplastic syndromes | View |
| refractory cytopenia with multilineage dysplasia | View |
| atypical chronic myeloid leukemia | View |